View in EDS HTML Full Text PDF Full Text

The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab.

Saved in:
Bibliographic Details
Title: The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab.
Authors: Kuźniewska, Alicja1 (AUTHOR) alicja.kuzniewska@gumed.edu.pl, Majeranowski, Alan1,2 (AUTHOR) alan.majeranowski@gumed.edu.pl, Henry, Sara1 (AUTHOR) sarahenry48@gmail.com, Kowalska, Daria1 (AUTHOR) daria.kowalska@gumed.edu.pl, Stasiłojć, Grzegorz1 (AUTHOR) gstasilojc@gumed.edu.pl, Urban, Aleksandra1 (AUTHOR) aleksandra.urban@gumed.edu.pl, Zaucha, Jan M.2 (AUTHOR), Okrój, Marcin1 (AUTHOR) marcin.okroj@gumed.edu.pl
Source: Cancers. Jan2024, Vol. 16 Issue 1, p49. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers16010049